NVO - NOVO NORDISK A S

QQQ $ 436.31 $ -1.49 (-0.34 %)

DIA $ 387.74 $ 0.69 (0.18 %)

SPY $ 518.99 $ -0.53 (-0.1 %)

TLT $ 98.26 $ 0.22 (0.22 %)

GLD $ 221.49 $ 0.04 (0.02 %)

Previous Close

$ 126

Open

$ 128.55

Bid

$ 128.57 x 100

Ask

-- x --

Day's Range

$ 128.43 - $ 129.16

52 Week Range

$ 78.70 - $ 148.15

Volume

5,857,609

Average Volume

Market Cap

568,260

Beta (5Y Monthly)

$ 0.66

PE Ratio (TTM)

$ 0.00

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Reiterates Overweight on...
08/05/2024 18:04:29

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

eli-lillys-zepbound-challenges-novo-nordisks-wegovy-amid-supply-issues

Eli Lilly's Zepbound Challenges Novo Nordi...
08/05/2024 15:59:28

Eli Lilly's Zepbound and Novo Nordisk's Wegovy face supply shortages, influencing doctors' prescribing habits. Both...

after-ozempic-and-botox-hollywood-is-going-gaga-over-this-new-anti-aging-supplement

After Ozempic And Botox, Hollywood Is Goin...
08/05/2024 14:43:09

This trend is gaining momentum although its effectiveness is yet to be determined.

using-weight-loss-medications-such-as-wegovy-zepbound-psychologist-warns-of-linked-eating-disorder-risks

Using Weight Loss Medications Such As Wego...
08/02/2024 16:31:22

Psychologists warn of increased eating disorders linked to popular GLP-1 weight loss drugs like Wegovy and Zepbound. Experts ur...

1000-invested-in-this-stock-10-years-ago-would-be-worth-5600-today

$1000 Invested In This Stock 10 Years Ago ...
08/02/2024 15:30:35

Lilly CEO Sees Weight-Loss Drug Shortage E...
08/01/2024 16:45:26

Bloomberg

Smart Money Is Betting Big In NVO Options
07/31/2024 16:01:08

fda-warns-of-overdose-risks-with-compounded-wegovy-ozempic-injections

FDA Warns Of Overdose Risks With Compounde...
07/30/2024 19:02:35

FDA reports hospitalizations due to overdoses from compounded semaglutide products. Patients and health care providers miscalcu...

novo-nordisks-older-weight-loss-drug-may-slow-cognitive-decline-in-alzheimers-patients-small-study-shows-brain-protecting-benefits

Novo Nordisk's Older Weight Loss Drug May ...
07/30/2024 18:09:44

Liraglutide shows promise in slowing cognitive decline in Alzheimer's patients, reducing brain volume loss and offering neu...

novo-nordisks-ozempic-reduces-smoking-related-health-interventions-in-diabetic-patients-study-finds

Novo Nordisk's Ozempic Reduces Smoking-Rel...
07/30/2024 14:52:20

A study finds smokers with diabetes on Ozempic have fewer smoking-related medical interactions and interventions compared to th...

novo-nordisk-unusual-options-activity-for-july-26

Novo Nordisk Unusual Options Activity For ...
07/26/2024 19:01:12

FDA Alerts Health Care Providers, Compound...
07/26/2024 13:49:27

- Reuters

novo-nordisk-shares-decline-amid-competitive-pressure

Novo Nordisk Shares Decline Amid Competiti...
07/25/2024 20:25:21

Novo Nordisk A/S Common Stock (NYSE: NVO) experienced a notable decline on Thursday. This movement follows a significant announ...

viking-therapeutics-stock-surges-as-company-advances-weight-loss-drug-to-late-stage-trial-what-investors-need-to-know

Viking Therapeutics Stock Surges As Compan...
07/25/2024 17:48:03

Viking Therapeutics Inc (NASDAQ:VKTX) shares are rising Thursday after the biotech company announced plans to advance its exper...

novo-nordisks-options-frenzy-what-you-need-to-know

Novo Nordisk's Options Frenzy: What You Ne...
07/25/2024 14:46:04

uks-nhs-prescribes-weight-loss-drug-wegovy-less-than-expected-due-to-service-shortages

UK's NHS Prescribes Weight-Loss Drug Wegov...
07/24/2024 18:58:07

The NHS has prescribed Wegovy far less often than expected due to a shortage of weight management clinics, highlighting signifi...

novo-nordisks-stock-dips-in-pre-market-despite-winning-uks-approval-of-weight-loss-drug-whats-going-on

Novo Nordisk's Stock Dips In Pre-Market De...
07/24/2024 10:57:33

Wegovy, a GLP-1 receptor agonist, had previously been approved for use in obesity treatment and weight management.

insulin-device-maker-embecta-weighs-sale-after-70-share-decline-following-becton-dickinson-spin-off

Insulin Device Maker Embecta Weighs Sale A...
07/23/2024 19:05:41

Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The comp...

britains-drug-regulator-approves-novo-nordisks-weight-loss-drug-wegovy-to-cut-heart-disease-risk-in-obese-patients

Britain's Drug Regulator Approves Novo Nor...
07/23/2024 18:40:39

The U.K. MHRA has approved Novo Nordisk's Wegovy (semaglutide) to prevent cardiovascular issues in overweight and obese adu...

Novo's Weight-Loss Drug Wegovy Receives UK...
07/23/2024 14:41:27

- Bloomberg